AU2003215190A1 - Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. - Google Patents

Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.

Info

Publication number
AU2003215190A1
AU2003215190A1 AU2003215190A AU2003215190A AU2003215190A1 AU 2003215190 A1 AU2003215190 A1 AU 2003215190A1 AU 2003215190 A AU2003215190 A AU 2003215190A AU 2003215190 A AU2003215190 A AU 2003215190A AU 2003215190 A1 AU2003215190 A1 AU 2003215190A1
Authority
AU
Australia
Prior art keywords
hiv
molecules
compositions
methods
related disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003215190A
Other languages
English (en)
Other versions
AU2003215190A8 (en
Inventor
Douglas M. Powell
Nadine S. Weich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2003215190A1 publication Critical patent/AU2003215190A1/en
Publication of AU2003215190A8 publication Critical patent/AU2003215190A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003215190A 2002-02-15 2003-02-13 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules. Abandoned AU2003215190A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US35739102P 2002-02-15 2002-02-15
US60/357,391 2002-02-15
US38024902P 2002-05-13 2002-05-13
US60/380,249 2002-05-13
US39130602P 2002-06-25 2002-06-25
US60/391,306 2002-06-25
US40629702P 2002-08-27 2002-08-27
US60/406,297 2002-08-27
US41200702P 2002-09-19 2002-09-19
US60/412,007 2002-09-19
US41750802P 2002-10-10 2002-10-10
US60/417,508 2002-10-10
US43231802P 2002-12-10 2002-12-10
US60/432,318 2002-12-10
PCT/US2003/004246 WO2003070883A2 (en) 2002-02-15 2003-02-13 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.

Publications (2)

Publication Number Publication Date
AU2003215190A1 true AU2003215190A1 (en) 2003-09-09
AU2003215190A8 AU2003215190A8 (en) 2003-09-09

Family

ID=27761699

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003215190A Abandoned AU2003215190A1 (en) 2002-02-15 2003-02-13 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.

Country Status (5)

Country Link
US (2) US20030216288A1 (enExample)
EP (1) EP1474535A4 (enExample)
JP (1) JP2005535289A (enExample)
AU (1) AU2003215190A1 (enExample)
WO (1) WO2003070883A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2838742B1 (fr) * 2002-04-23 2004-07-09 Inst Nat Sante Rech Med Epitopes t de l'antigene epha2
WO2005101003A1 (en) * 2004-04-13 2005-10-27 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with purinoceptor 4 type y (p2y4)
WO2006010497A2 (en) * 2004-07-28 2006-02-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with choline kinase (chk)
WO2008006850A2 (en) * 2006-07-11 2008-01-17 Urban Scheuring Compositions and methods for inhibiting hiv infections by inhibiting lerepo4 and glipr
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
CA2902061C (en) 2013-02-28 2023-08-08 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
IL299978B2 (en) 2015-03-10 2024-08-01 Hemanext Inc Single-use oxygen reduction kits, devices and methods for their use
EP3285711A4 (en) 2015-04-23 2018-11-07 New Health Sciences, Inc. Anaerobic blood storage containers
EP4623991A3 (en) 2015-05-18 2025-12-17 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
EP3463466B1 (en) 2016-05-27 2022-02-16 Hemanext Inc. Anaerobic blood storage and pathogen inactivation method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE324877T1 (de) * 1999-08-17 2006-06-15 Purdue Research Foundation Behandlung von metastatischer krankheit
US6482935B1 (en) * 2000-05-24 2002-11-19 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
US6492156B1 (en) * 2001-10-31 2002-12-10 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof

Also Published As

Publication number Publication date
EP1474535A4 (en) 2006-11-08
US20070031882A1 (en) 2007-02-08
WO2003070883A3 (en) 2004-07-15
WO2003070883A2 (en) 2003-08-28
AU2003215190A8 (en) 2003-09-09
US20030216288A1 (en) 2003-11-20
EP1474535A2 (en) 2004-11-10
JP2005535289A (ja) 2005-11-24

Similar Documents

Publication Publication Date Title
EP1583821A4 (en) METHODS AND COMPOSITIONS FOR TREATING UROLOGICAL DISORDERS USING GENES 44390, 54181, 211, 5687, 884, 1405, 636, 4421, 5410, 30905, 2045, 16405, 18560, 2047, 33751, 52872, 14063, 20739, 32544, 43239, 44373, 51164, 53010, 16852, 1587, 2207, 22245, 2387, 52908, 69112, 14990, 18547, 115, 579
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
AU2003238561A1 (en) Compositions and methods for treating gynaecological disorders
AU2001269799A1 (en) Methods for treating various eye disorders
WO2004058153A9 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
AU2003210597A1 (en) Methods for treating eye disorders
AU2003215190A1 (en) Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
AU2003222022A1 (en) Methods for treating deodorizer distillate
AU2001244834A1 (en) Novel strain for decomposing tmah, and method of wastewater treatment using the same
AU2003237657A1 (en) Means and methods for improved treatment using "setrones"
EP1471818A4 (en) METHOD AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISEASES USING 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137 , 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 OR 13249 MOLECULES
AU2003210554A1 (en) Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
EP1601799A4 (en) METHODS AND COMPOSITIONS FOR TREATING AIDS AND HIV-ASSOCIATED DISEASES USING 9145, 1725, 311, 837, 58305, 156, 14175, 50352, 32678, 5560, 7240, 8865, 12396, 12397, 13644, 19938, 2077, 1735 , 1786, 10220, 17822, 33945, 43748, 47161, 81982, OR 46777
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2003275433A1 (en) Compositions and methods for treating pain
AU2003202255A1 (en) Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
AU2003297259A1 (en) Methods and compositions for treating neurological disorders
AU2003278935A1 (en) Method and composition for treating neurodegenerative disorders
AU2002361711A1 (en) METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832
AU2002359362A1 (en) Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
EP1441684A4 (en) METHODS AND COMPOSITIONS FOR TREATING UROLOGICAL DISORDERS USING 313, 333, 5464, 18817 OR 33524
AU2001295689A1 (en) Compositions and methods for regulating the nervous system
AU2001236909A1 (en) Method of treating disorders of the eye

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase